Different efficacy of EGFR tyrosine kinase inhibitors and prognosis in patients with subtypes of EGFR-mutated advanced non-small cell lung cancer: a meta-analysis
Crossref DOI link: https://doi.org/10.1007/s00432-014-1709-0
Published Online: 2014-06-08
Published Print: 2014-11
Update policy: https://doi.org/10.1007/springer_crossmark_policy
Wang, Huan
Huang, Jing
Yu, Xiaojin
Han, Shuhua
Yan, Xing
Sun, Siqing
Zhu, Xiaoli
License valid from 2014-06-08